Bottom line
PSIL vs ASD: the short answer
PSIL (AdvisorShares Psychedelics ETF) and ASD (Defiance Autism Impact ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared.
ASD is cheaper at 0.79% vs 1% — a difference of $21 a year per $10,000 invested.
Updated Nov 19, 2026
PSIL vs ASD side by side
| PSIL | ASD | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Advisorshares | Grayscale |
| Category | Large Blend | Large Blend |
| Expense ratio | 1% | 0.79% |
| Annual cost per $10k | $100 | $79 |
| 10-yr cost on $10k (prospectus) | $1,521 | — |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +73.4% | — |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +46.6% | — |
| Worst quarter | −32.3% | — |
| Net assets (fund) | $44.4M | $1.4M |
| Number of holdings | 32 | 39 |
| Portfolio turnover | 64% | — |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
4 of PSIL's top 25 holdings also appear in ASD's top 25.
| Holding | PSIL | ASD |
|---|---|---|
| Definium Therapeutics Inc | 12.85% | 4.77% |
| Abbvie Inc | 4.14% | 2.72% |
| Johnson & Johnson | 3.61% | 2.59% |
| Supernus Pharmaceuticals Inc | 2.89% | 2.50% |
Source: SEC Form N-PORT
PSIL top 10
- Definium Therapeutics Inc — 12.85%
- Compass Pathways Plc — 11.45%
- Ataibeckley Inc — 10.47%
- Relmada Therapeutics Inc — 6.84%
- Nrx Pharmaceuticals Inc — 6.07%
- Neurocrine Biosciences Inc — 4.38%
- Cybin Inc — 4.35%
- Gh Research Plc — 4.31%
- Alkermes Plc — 4.30%
- Alto Neuroscience Inc — 4.20%
ASD top 10
- Definium Therapeutics Inc — 4.77%
- Neuren Pharmaceuticals Ltd — 3.23%
- LifeStance Health Group Inc — 3.04%
- Otsuka Holdings Co Ltd — 2.95%
- Acadia Healthcare Co Inc — 2.90%
- ACADIA Pharmaceuticals Inc — 2.89%
- MapLight Therapeutics Inc — 2.89%
- AbbVie Inc — 2.72%
- BrightSpring Health Services I — 2.70%
- Revvity Inc — 2.68%
FAQ
What is the difference between PSIL and ASD?
PSIL (AdvisorShares Psychedelics ETF) and ASD (Defiance Autism Impact ETF) are quite different portfolios: only about 17% of their top holdings (by weight) are shared. ASD is cheaper at 0.79% vs 1% — a difference of $21 a year per $10,000 invested.
Which is cheaper, PSIL or ASD?
ASD has the lower expense ratio (0.79%).
Should I own both PSIL and ASD?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.